Transient Coma and Signs of Encephalopathy Related to 5-Fluorouracil and Carboplatin: A Case Report
Chemotherapy-related encephalopathy is a rare but severe side effect of cancer therapy. Few reports exist on the course of encephalopathy due to 5-fluorouracil (5FU)/carboplatin treatment. Here, we report on a patient in his 70s, who received first-line palliative treatment with carboplatin followed...
Main Authors: | Mark Zupancic, Pedro Farrajota Neves da Silva, Karam Kas Elyas, Signe Friesland, Thomasine Ellingsen Cederö, Marco Gerling |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2023-07-01
|
Series: | Case Reports in Oncology |
Subjects: | |
Online Access: | https://beta.karger.com/Article/FullText/531472 |
Similar Items
-
A unique presentation of 5-fluorouracil (5-FU) induced cerebral encephalopathy
by: Shailendra S Naik, et al.
Published: (2020-04-01) -
Comparing the Efficacy of Carboplatin plus 5-Fluorouracil, Cisplatin plus 5-Fluorouracil, and Best Supportive Care for Advanced Esophageal Squamous Cell Carcinoma: A Propensity Score Analysis from a Tertiary Hospital in Southern Thailand
by: Jirapat Wonglhow, et al.
Published: (2024-03-01) -
Definitive concurrent chemoradiotherapy with paclitaxel plus carboplatin is superior to cisplatin plus 5‐fluorouracil in patients with inoperable esophageal squamous cell carcinoma using retrospective, real‐world evidence
by: Jason Chia‐Hsun Hsieh, et al.
Published: (2021-12-01) -
Wernicke’s Encephalopathy in Colon Cancer
by: Berrin Papila, et al.
Published: (2010-10-01) -
THE DIFFERENCES OF APOPTOSIS EFFECTS BETWEEN COMBINATION OF MELOXICAM WITH GEMCITABINE-CARBOPLATIN CHEMOTHERAPY COMPARED TO GEMCITABINE-CARBOPLATIN CHEMOTHERAPY ALONE IN UROTHELIAL CARCINOMA CULTURE CELLS
by: Ananta Cahyo Nugroho, et al.
Published: (2019-01-01)